A Study shows mutation-resistant antibodies with 269×affinity, a proof point for CEPI’s 100 Days Mission and closing ...
Vinay Prasad, the Trump administration regulator who angered pharma companies and crushed the hopes of patients with rare diseases with a series of controversial decisions to reject new drug ...